Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra

This publication has 10 references indexed in Scilit:

• Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
  Annals of the Rheumatic Diseases, 2007
• Familial Mediterranean Fever Successfully Treated With Etanercept
  JCR: Journal of Clinical Rheumatology, 2007
• Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
  New England Journal of Medicine, 2006
• Safety of extended treatment with anakinra in patients with rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2006
• The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production
  Proceedings of the National Academy of Sciences, 2006
• Familial Mediterranean fever responds well to infliximab: single case experience
  Clinical Rheumatology, 2005
• Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis
  Arthritis & Rheumatism, 2005
• Anakinra for flares of pyogenic arthritis in PAPA syndrome
  Rheumatology, 2005
• Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist
  The Lancet, 2004
• Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
  New England Journal of Medicine, 2003